Mironid secures £4.3 million in Series A funding
20 June 2016 | By Victoria White, Digital Content Producer
The funding, led by Epidarex Capital, will support the Mironid’s internal research and preclinical development programmes...
List view / Grid view
20 June 2016 | By Victoria White, Digital Content Producer
The funding, led by Epidarex Capital, will support the Mironid’s internal research and preclinical development programmes...
20 June 2016 | By Victoria White, Digital Content Producer
The new findings on thalidomide, from researchers at the Technical University of Munich (TUM), are highly relevant to current cancer therapies...
17 June 2016 | By Victoria White, Digital Content Producer
Cell Medica has entered into a co-development partnership with Baylor to develop technologies for engineering immune cells with enhanced functions...
17 June 2016 | By Victoria White, Digital Content Producer
Tri-I TDI will extend its current relationship with Takeda from the realm of small molecule discovery into the new research area of antibody drug discovery...
16 June 2016 | By Victoria White, Digital Content Producer
Researchers believe understanding the anti-cancer mechanisms of naked mole-rats may help advance human treatment in the future...
15 June 2016 | By Victoria White, Digital Content Producer
An analysis of changes in the intestinal microbial population during the first three years of life has revealed some of the impacts of antibiotic exposure...
15 June 2016 | By Victoria White, Digital Content Producer
Scientists from The Scripps Research Institute have developed a powerful new method for finding drug candidates that bind to specific proteins...
15 June 2016 | By Victoria White, Digital Content Producer
According to a study, genetic research in large-scale prospective biobank studies can significantly improve the drug development pipeline and reduce costs...
14 June 2016 | By Mandy Parrett, Editorial Assistant
In the face of the enormous costs involved in bringing a drug to market, pharmaceutical companies are increasingly aiming to develop first-in-class treatments to maximise return on this heavy burden, notes intelligence provider, GBI Research.
14 June 2016 | By Victoria White, Digital Content Producer
The combination of TXA709 with cefdinir, an antibiotic that has been on the market for almost two decades, successfully treated MRSA infection in animals...
13 June 2016 | By Victoria White, Digital Content Producer
Scientists at EPFL have found a way to starve liver cancer cells by blocking a protein that is required for glutamine breakdown - LRH-1...
13 June 2016 | By Victoria White, Digital Content Producer
Researchers at EPFL have found a way to reclaim the corrupted immune cells, turn them into signals for the immune system to attack the tumour...
13 June 2016 | By Victoria White, Digital Content Producer
Researchers have unveiled a novel radioimmunotherapy that resulted in complete remission of colorectal cancer in mouse models...
13 June 2016 | By Victoria White, Digital Content Producer
Results from a study showed that JQ1 slowed tumour growth and limited the number of blood vessels that were produced...
9 June 2016 | By Victoria White, Digital Content Producer
A new method, developed by UCLA scientists, could eventually lead to a way to improve accuracy of how well a patient will respond to treatment...